01 November 1999
Native tetanus and pertussis toxins effect on electrical and chemical seizures in mice
Roman KorolkiewiczMed Sci Monit 1999; 5(6): BR1081-1089 :: ID: 503101
Abstract
The tetanus toxin (Tetx) administered intracerebroventricularly (i.c.v.) or intraperitoneally (i.p.) caused the death of 50% of experimental mice (LD50,) at a dose of 18.0 (11.5-28.2) MLDs or 11.0 (8.3-14.6) MLDs/kg each. The minimal lethal dose (MLD) is defined as the lowest dose of Tetx required to kill a 20.0 g albino mouse within 96 hours following i.p. treatment [24]. Tetx increased the convulsive threshold of the electrical current and diminished particular chemical convulsant potencies. At the same time Tetx increased the protection given by a number of anti-epileptics during maximal electroshock treatment (MES). There were no marked γ-aminobutyric acid (GABA) concentration and total L-glutamic acid decarboxylase activity changes(GAD) in whole-brain homogenates accompanying Tetx treatment. These results suggest the preponderance of inhibitory over excitatory transmission probably due to Tetx action at the neuronal level. Tetx that penetrates into the central nervous system (CNS) following an i.p. injection evokes changes similar to those noted during Tetx administration into the lateral ventricle. Thus, both routes of adminstration demonstrate comparable predictive values in describing Tetx-induced changes during convulsive thresholds. Pertussis toxins (0.5 µg/animal, i.c.v., 120 h prior to testing), enhanced the chemical convulsants potency and decreased the carbamazepine protection during MES. It remained without marked influence upon the action of diphenylhydantoin and diazepam. These observations suggest that the enhanced sensitivity towards a number of chemical convulsants, irrespective of their action possibly results from a functional suppression of the inhibitory transmission at receptors coupled with pertussis toxin sensitive G proteins, rather than due to direct action on the G protein linked excitatory neurotransmission. The attenuation of carbamazepine efficacy might result in the sum of adenosine receptor antagonist drug properties and transmission suppression at the level of adenosine receptors coupled with G proteins sensitive towards pertussis toxins. Both toxins did not influence the total plasma levels of any anti-epileptic drug. Thus, the observed interactions between Tetx/pertussis toxins and anti-epileptic drugs probably occur at the neuronal level.
Keywords: Electroshock, Pertussis Toxin, Tetanus Toxin
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952